MétaCan
Menu
Back to cohort
Record W4226193141 · doi:10.1097/meg.0000000000002029

Simplified care-pathway selection for nonspecialist practice: the GLOBAL Primary Biliary Cholangitis Study Group Age, Bilirubin, Alkaline phosphatase risk assessment tool

2020· article· en· W4226193141 on OpenAlexafffund
Carla Fiorella Murillo Perez, Aliya Gulamhusein, Marco Carbone, Palak Trivedi, Christophe Corpechot, Pier Maria Battezzati, Willem J. Lammers, Nora Cazzagon, Annarosa Floreani, Albert Parés, Frederik Nevens, Ana Lleò, Marlyn J. Mayo, Kris V. Kowdley, Cyriel Y. Ponsioen, George Ν. Dalekos, Nikolaos Gatselis, Douglas Thorburn, Andrew L. Mason, Harry L.A. Janssen, Xavier Verhelst, Tony Bruns, Keith D. Lindor, Olivier Chazouillères, Pietro Invernizzi, Bettina E. Hansen, Gideon M. Hirschfield

Bibliographic record

VenueEuropean Journal of Gastroenterology & Hepatology · 2020
Typearticle
Languageen
FieldMedicine
TopicLiver Diseases and Immunity
Canadian institutionsUniversity of TorontoUniversity of AlbertaToronto General HospitalUniversity Health Network
FundersAmerican Medical Association FoundationNovartis PharmaNorgineCilagAstellas PharmaEuropean Association for the Study of the LiverDr. Falk PharmaMinistero della SaluteGlaxoSmithKlineBristol-Myers SquibbFalk FoundationNational Institute for Health and Care ResearchCanadian Liver FoundationRegeneron PharmaceuticalsCanadian Institutes of Health ResearchIntercept PharmaceuticalsGilead Sciences
KeywordsMedicineBilirubinAlkaline phosphataseInternal medicineGastroenterologyUrsodeoxycholic acidSurgery

Abstract

fetched live from OpenAlex

Background Opportunity to redefine the care journeys for those living with primary biliary cholangitis (PBC) includes facilitating access to enhanced (PBC-dedicated) programmes by nonspecialist risk ‘flagging’ of patients. Objective To develop a nonexpert PBC stratification tool to help care pathway choices (standard vs. enhanced) choices in PBC. Methods We included ursodeoxycholic acid-treated patients with PBC from the Global PBC Study Group. The performance of baseline and 1-year clinical markers with transplant-free survival was assessed to develop the ‘ABA’ tool using Age (A), Bilirubin (B), and Alkaline phosphatase (A). Added value of fibrosis estimation was assessed. Results ‘ABA’ classification mapped three risk groups (n = 2226): low [Age > 50 years, bilirubin ≤ 1 × ULN, alkaline phosphatase (ALP) ≤ 3 × ULN], high (Age ≤ 50 years, bilirubin > 1 × ULN, ALP > 3 × ULN), and intermediate (other). Transplant-free survival at 10 years in the low-, intermediate-, and high-risk groups were 89, 77, and 59% at baseline and 86, 76, and 40% at 1 year, respectively. We propose that high-risk patients at baseline be directly triaged to enhanced (PBC-dedicated) care and the remaining be reassessed at 1 year. Modelling showed after 1 year 46% patients were proposed to enhanced care and 54% to standard care. The ‘ABA’ mapped pathways facilitated identification of patients at risk based on a young age, as compared to traditional liver biochemical stratification. In patients proposed to standard care, estimated fibrosis stage had ongoing prognostic value. Conclusion Nonspecialist use of the ‘ABA’ risk tool could prioritize care journey choices for patients with PBC.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.005
metaresearch head score (Gemma)0.013
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.006
Threshold uncertainty score0.026

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0050.013
Meta-epidemiology (narrow)0.0010.000
Meta-epidemiology (broad)0.0010.002
Bibliometrics0.0020.002
Science and technology studies0.0000.000
Scholarly communication0.0010.001
Open science0.0010.001
Research integrity0.0010.001
Insufficient payload (model declined to judge)0.0020.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.018
GPT teacher head0.292
Teacher spread0.274 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations5
Published2020
Admission routes2
Has abstractyes

Explore more

Same venueEuropean Journal of Gastroenterology & HepatologySame topicLiver Diseases and ImmunityFrench-language works237,207